Akiva Mintz

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Akiva Mintz sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials 5 currently recruiting early-phase tilt upper quartile by trial count

Akiva Mintz: 5 sponsored US clinical trials, 5 recruiting.

Akiva Mintz sponsors 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy Volunteer, with 4 trials.

Upper-quartile sponsor footprint

Akiva Mintz sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Akiva Mintz pipeline

5 recruiting of 5 indexed (100% open).

Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).

Top condition: Healthy Volunteer (4 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Akiva Mintz: open-pipeline peers nationwide

Peers matched on 5 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Akiva Mintz sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 123456 0%50%100%150% Total trials Recruiting share Akiva Mintz4YouandMeAbbott Rapid DxAccess Business GroupAcera SurgicalAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Akiva Mintz sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Akiva Mintz sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

What to do with this Akiva Mintz page

5 registered trials is a research-attention snapshot, not an endorsement of Akiva Mintz or any single study.

  • 5 of Akiva Mintz's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy Volunteer is the condition Akiva Mintz studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy Volunteer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Akiva Mintz pipeline card: 5 registered trials from official public datasets.Report a data error.